These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3215763)

  • 21. Risk of major bleeding during concomitant use of antibiotic drugs and coumarin anticoagulants.
    Penning-van Beest FJ; Koerselman J; Herings RM
    J Thromb Haemost; 2008 Feb; 6(2):284-90. PubMed ID: 18031295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prospective study of the potentiation of acenocoumarol by amiodarone.
    Richard C; Riou B; Berdeaux A; Fournier C; Khayat D; Rimailho A; Giudicelli JF; Auzépy P
    Eur J Clin Pharmacol; 1985; 28(6):625-9. PubMed ID: 4065185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between amiodarone and acenocoumarin.
    Pini M; Manotti C; Quintavalla R
    Thromb Haemost; 1985 Aug; 54(2):549. PubMed ID: 4082092
    [No Abstract]   [Full Text] [Related]  

  • 24. [Adverse effects of combined use of acenocoumarol and acetylsalicylic acid after myocardial infarct and unstable angina].
    Sámóczi M; Farkas A; Sipos E; Tarján J
    Orv Hetil; 1995 Jan; 136(4):177-9. PubMed ID: 7870411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laryngeal dyspnea in relation to an interaction between acenocoumarol and topical econazole lotion.
    Wey PF; Petitjeans F; Lions C; Ould-Ahmed M; Escarment J
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):173-7. PubMed ID: 18775393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Safety of aspirin, clopidogrel, and acenocumarol combination in patients requiring anticoagulation].
    Sánchez-Torrijos J; Gudín-Uriel M; Ridocci-Soriano F
    Rev Esp Cardiol; 2006 Dec; 59(12):1345-6. PubMed ID: 17194433
    [No Abstract]   [Full Text] [Related]  

  • 27. Hypervitaminosis E.
    Moharana S; Moharana DN
    Indian J Physiol Pharmacol; 1999 Jul; 43(3):407-9. PubMed ID: 10776496
    [No Abstract]   [Full Text] [Related]  

  • 28. [Complications of oral anticoagulant therapy in patients with valvular prosthesis (author's transl)].
    Goich J; Bianchi C; Meruane J; Suarez L; Katz R
    Rev Med Chil; 1980 Aug; 108(8):712-5. PubMed ID: 7221258
    [No Abstract]   [Full Text] [Related]  

  • 29. The potentiation of acenocoumarol anticoagulant effect by amiodarone.
    Arboix M; Frati ME; Laporte JR
    Br J Clin Pharmacol; 1984 Sep; 18(3):355-60. PubMed ID: 6487475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low molecular weight heparin (enoxaparin) versus oral anticoagulant therapy (acenocoumarol) in the long-term treatment of deep venous thrombosis in the elderly: a randomized trial.
    Veiga F; Escribá A; Maluenda MP; López Rubio M; Margalet I; Lezana A; Gallego J; Ribera JM
    Thromb Haemost; 2000 Oct; 84(4):559-64. PubMed ID: 11057850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acenocoumarol stabilization is delayed in CYP2C93 carriers.
    Schalekamp T; van Geest-Daalderop JH; de Vries-Goldschmeding H; Conemans J; Bernsen Mj Mj; de Boer A
    Clin Pharmacol Ther; 2004 May; 75(5):394-402. PubMed ID: 15116052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochrome P450 2C9 polymorphism and acenocoumarol therapy.
    Mark L; Marki-Zay J; Fodor L; Hajdara I; Paragh G; Katona A
    Kardiol Pol; 2006 Apr; 64(4):397-402; discussion 403-4. PubMed ID: 16699986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Significance of cytochrome P450 2C9 genotype for the bleeding complications in patients treated with acenocoumarol].
    Márk L; Márki-Zay J; Fodor L; Kondacs A; Paragh G; Katona A
    Orv Hetil; 2005 Apr; 146(16):739-43. PubMed ID: 15889670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spontaneous retroperitoneal hemorrhage and anticoagulant treatment: presentation of 4 cases and review of the literature].
    Estivill X; Domingo P; Fontcuberta J; Félez J
    Med Clin (Barc); 1984 Nov; 83(14):587-92. PubMed ID: 6513649
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pulmonary hemorrhage caused by the interaction of acenocoumarin and sodium diclofenac].
    Cuadrado Gómez LM; Palau Beato E; Pérez Venegas J; Pérez Moro E
    Rev Clin Esp; 1987 Sep; 181(4):227-8. PubMed ID: 3671847
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemorrhagic complications in anticoagulant therapy].
    Pavlosky M; Carreras LO; Lazzari MA; Albertal J
    Medicina (B Aires); 1981; 41 Suppl():274-7. PubMed ID: 7345348
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol).
    Pattacini C; Manotti C; Pini M; Quintavalla R; Dettori AG
    Thromb Haemost; 1994 Feb; 71(2):188-91. PubMed ID: 8191397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The blue toe syndrome during oral anticoagulant therapy with acenocoumarol.
    Fernández MA; Andreu R; Fortea JM; Aznar J
    Thromb Haemost; 2001 Apr; 85(4):743. PubMed ID: 11341514
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between mianserin and acenocoumarin: a single case study.
    Baettig D; Tillement JP; Baumann P
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):165-7. PubMed ID: 8032574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical use of heparin-heparinoid-mixtures].
    Hörder MH; Stier WD; Brunswig D
    Arzneimittelforschung; 1969 Nov; 19(11):1873-6. PubMed ID: 4190000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.